4//SEC Filing
Aclaris Therapeutics, Inc. 4
Accession 0001209191-15-086746
$ACRSCIK 0001557746operating
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 8:04 PM ET
Size
5.4 KB
Accession
0001209191-15-086746
Insider Transaction Report
Form 4
Tullman Stephen A.
Director
Transactions
- Award
Stock option (right to buy)
2015-12-18+7,095→ 7,095 totalExercise: $28.68Exp: 2025-12-17→ Common Stock (7,095 underlying)
Footnotes (1)
- [F1]25% of the shares underlying this option will vest on December 18, 2016 and the remaining shares vest in 36 equal monthly installments thereafter, subject to the reporting person's continued service with the issuer as of the applicable vesting date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001557746
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 8:04 PM ET
- Size
- 5.4 KB